Myelodysplastic syndromes spatial clusters in disease etiology and outcome
- 5 October 2015
- journal article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 57 (2) , 392-399
Abstract
The myelodysplastic syndromes (MDS) are a heterogeneous group of hematopoietic disorders. This study aims to advance the use of spatial modeling in disease etiology and monitoring based on reports on a large population (n = 984) of MDS patients diagnosed in the Eastern United States. The spatial MDS clustering was analyzed using SaTScan, and patient clinical characteristics were analyzed using logistic regression and Cox hazards models adjusting for covariates. One main and five secondary spatial clusters (p-value < 10-17-10-7) were identified. Patients living in high vs. low MDS incidence clusters tended to be older (ORadj = 1.04 [1.004, 1.07]) and smokers (ORadj = 2.9 [1.1, 7.4]). Mortality was associated with hemoglobin (HRadj = 0.7 [0.5, 0.9]), neutrophils (HRadj = 0.7 [0.6, 0.96]), platelets (HRadj = 0.5 [0.4, 0.7]), and blast (HRadj = 1.4 [1.1, 1.8]), but not clusters. The results suggest large geographic variations in MDS incidence rates. The biological aggressiveness of the disease is unlikely to be associated with its spatial distribution.Keywords
This publication has 33 references indexed in Scilit:
- Trends in incidence, initial treatment and survival of myelodysplastic syndromes: A population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010European Journal of Cancer, 2014
- The Genetic Basis and Expanding Role of Molecular Analysis in the Diagnosis, Prognosis, and Therapeutic Design for Myelodysplastic SyndromesThe Journal of Molecular Diagnostics, 2014
- Evaluation of epidemiological factors in survival of patients with de novo myelodysplastic syndromesCancer Causes & Control, 2014
- High rate of uncaptured myelodysplastic syndrome cases and an improved method of case ascertainmentLeukemia Research, 2014
- Prognostic features of patients with myelodysplastic syndromes aged < 50 years: update of a single-institution experienceLeukemia & Lymphoma, 2012
- Baseline characteristics and predictors of outcome in patients with myelodysplastic syndromes living in Western PennsylvaniaLeukemia & Lymphoma, 2011
- Characteristics of US Patients with Myelodysplastic Syndromes: Results of Six Cross-sectional Physician SurveysJNCI: Journal of the National Cancer Institute, 2008
- Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programsBlood, 2008
- Myelodysplastic syndromesCancer, 2007
- The prognostic impact of karyotypic subgroups in myelodysplastic syndromes is strongly modified by sexBritish Journal of Haematology, 2001